Eikonizo Therapeutics
Pre-clinicalEikonizo is developing disease-modifying therapies by creating brain penetrant and peripheral small molecules to improve the lives of people impacted by neurodegenerative, cardiorenal and other diseases.
Founded
2020
Focus
Small Molecules
About
Eikonizo is developing disease-modifying therapies by creating brain penetrant and peripheral small molecules to improve the lives of people impacted by neurodegenerative, cardiorenal and other diseases.
Funding History
1SeedUndisclosedUndisclosedJun 15, 2023
Company Info
TypePrivate
Founded2020
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile